Brain Tumor Immunotherapy

個数:

Brain Tumor Immunotherapy

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 360 p.
  • 言語 ENG
  • 商品コード 9781617371103
  • DDC分類 617

Full Description

An authoritative panel of researchers and clinicians critically reviews the entire field to provide a comprehensive guide to modern brain tumor immunotherapy and thereby enhance future research in this area. The contributors detail many of the key laboratory experiments and clinical protocols that are currently being investigated, integrate the available information from previous and ongoing research, and help define the current status of the field. Topics range from adoptive cellular and antibody-mediated immunotherapy of brain tumors to tumor vaccines and related strategies, and include many vanguard experimental strategies and immunological techniques for studying brain tumor immunotherapy. Cutting-edge and comprehensive, Brain Tumor Immunotherapy brings together all the important recent advances in our understanding of central nervous system tumor immunology and illustrates in powerful detail the many new applications now harnessing the immune response for brain tumor therapeutics.

Contents

Part I. Introduction to the Disease. Neuropathology and Molecular Pathogenesis of Primary Brain Tumors, Paul S. Mischel and Harry V. Vinters. Epidemiology of Primary Brain Tumors, Susan Preston-Martin, Faith Davis, and Roberta McKean-Cowdin. Current Therapy for Primary Brain Tumors, John M. Duff, Pierre-Yves Dietrich, and Nicolas de Tribolet. Part II. Introduction to Immunotherapy of Brain Tumors. Immunostimulation and Immunomodulation of Brain Tumors, Victor C. K. Tse and Frances K. Conley. Biological Principles of Brain Tumor Immunotherapy, Amy B. Heimberger, Darell D. Bigner, and John H. Sampson. Part III. Adoptive Cellular Immunotherapy of Brain Tumors. Systemic T-Cell Immunotherapy for Brain Tumors, Gregory E. Plautz and Suyu Shu. Cytotoxic T-Lymphocytes Reactive to Patient Major Histocompatibility Complex Proteins for Therapy of Brain Tumors, Carol A. Kruse and David Rubinstein. Autologous Vaccine and Adoptive Cellular Immunotherapy as Treatment for Brain Tumors, Gary W. Wood and Frank P. Holladay. Part IV. Antibody-Mediated Immunotherapy of Brain Tumors. Anti-Idiotype Immunotherapy Strategies for Brain Tumors, Nai-Kong V. Cheung. Radiolabeled Antibodies for Therapy of Brain Tumors, Carol J. Wikstrand, Michael R. Zalutsky, and Darell D. Bigner. Immunotoxin Therapy of Brain Tumors, Walter A. Hall. Antibodies to Adhesion Molecules for Immunotherapy of Brain Tumors, S. Ather Enam. Part V. Tumor Vaccines and Other Strategies. Cytokine-Based Immuno-Gene Therapy for Brain Tumors, Roberta P. Glick, Terry Lichtor, and Edward P. Cohen. Downregulation of Transforming Growth Factor b as Therapeutic Approach for Brain Tumors, Habib Fakhrai, Svetlana Gramatikova, and Rohangiz Safaei. Dendritic Cell Immunotherapy for Brain Tumors, Stéphane Vandenabeele, Linda M. Liau, andDavid Ashley. Death Ligand/Death Receptor-Mediated Apoptosis for Treatment of Brain Tumors, Wilfried Roth and Michael Weller. Combining Radiation Therapy with Immunotherapy for Treatment of Brain Tumors,William H. McBride. Index.

最近チェックした商品